Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference
Boston Scientific (NYSE: BSX) has announced its participation in the 2024 UBS Global Healthcare Conference scheduled for Tuesday, November 12, 2024. The company will be represented by Nick Spadea-Anello, president of Electrophysiology, and Jon Monson, senior vice president of Investor Relations, who will engage in a 35-minute Q&A session starting at 7:15 a.m. PT / 10:15 a.m. ET. The session will be available via live webcast, with a replay accessible approximately one hour after the event's conclusion on the company's investor relations website.
Boston Scientific (NYSE: BSX) ha annunciato la sua partecipazione alla Conferenza Globale sulla Salute UBS 2024, prevista per martedì 12 novembre 2024. L'azienda sarà rappresentata da Nick Spadea-Anello, presidente della Elettrofisiologia, e Jon Monson, vicepresidente senior delle Relazioni con gli Investitori, che parteciperanno a una sessione di domande e risposte di 35 minuti che inizierà alle 7:15 PT / 10:15 ET. La sessione sarà disponibile in diretta tramite webcast, con una replica accessibile circa un'ora dopo la conclusione dell'evento sul sito web delle relazioni con gli investitori dell'azienda.
Boston Scientific (NYSE: BSX) ha anunciado su participación en la Conferencia Global de Salud UBS 2024 programada para el martes 12 de noviembre de 2024. La empresa estará representada por Nick Spadea-Anello, presidente de Electrofisiología, y Jon Monson, vicepresidente senior de Relaciones con Inversores, quienes participarán en una sesión de preguntas y respuestas de 35 minutos que comenzará a las 7:15 a.m. PT / 10:15 a.m. ET. La sesión estará disponible a través de una transmisión en vivo, con una repetición accesible aproximadamente una hora después de la conclusión del evento en el sitio web de relaciones con inversores de la empresa.
Boston Scientific (NYSE: BSX)는 2024년 11월 12일 화요일로 예정된 2024 UBS 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 회사는 Nick Spadea-Anello 전기생리학 회장과 Jon Monson 투자자 관계 수석 부사장이 대표로 참석하며, 오전 7:15 PT / 오전 10:15 ET부터 35분 간의 Q&A 세션에 참여합니다. 이 세션은 라이브 웹캐스트를 통해 제공되며, 이벤트 종료 약 1시간 후에는 회사의 투자자 관계 웹사이트에서 재생할 수 있습니다.
Boston Scientific (NYSE: BSX) a annoncé sa participation à la Conférence Mondiale sur la Santé UBS 2024, prévue pour le mardi 12 novembre 2024. La société sera représentée par Nick Spadea-Anello, président de l'Électrophysiologie, et Jon Monson, vice-président senior des Relations avec les Investisseurs, qui participeront à une session de questions-réponses de 35 minutes débutant à 7h15 PT / 10h15 ET. La session sera disponible en direct par webcast, avec un replay accessible environ une heure après la fin de l'événement sur le site web des relations avec les investisseurs de l'entreprise.
Boston Scientific (NYSE: BSX) hat seine Teilnahme an der 2024 UBS Global Healthcare Conference angekündigt, die für Dienstag, den 12. November 2024, geplant ist. Das Unternehmen wird vertreten durch Nick Spadea-Anello, Präsident der Elektrophysiologie, und Jon Monson, Senior Vice President für Investor Relations, die an einer 35-minütigen Fragen-und-Antworten-Sitzung teilnehmen werden, die um 7:15 Uhr PT / 10:15 Uhr ET beginnt. Die Sitzung wird live über ein Webcast verfügbar sein, mit einer Wiederholung, die etwa eine Stunde nach Abschluss der Veranstaltung auf der Investor-Relations-Website des Unternehmens zugänglich ist.
- None.
- None.
Nick Spadea-Anello, president, Electrophysiology, and Jon Monson, senior vice president, Investor Relations, will participate in a 35-minute question-and-answer session with the host analyst at approximately 7:15 a.m. PT / 10:15 a.m. ET. A live webcast and replay of the session will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-the-2024-ubs-global-healthcare-conference-302296287.html
SOURCE Boston Scientific Corporation
FAQ
When is Boston Scientific (BSX) presenting at the 2024 UBS Global Healthcare Conference?
Who will represent Boston Scientific (BSX) at the 2024 UBS Healthcare Conference?
How long will Boston Scientific's (BSX) presentation be at the UBS Healthcare Conference?
Where can I watch Boston Scientific's (BSX) UBS Conference presentation?
